We are live on ! Find out more
5VM

5AM Venture Management Portfolio holdings

AUM $360M
1-Year Est. Return 345.76%
This Fund
S&P 500
This Quarter Est. Return
+62.83%
1 Year Est. Return
+345.76%
3 Year Est. Return
+491.51%
5 Year Est. Return
+330.26%
10 Year Est. Return
–
AUM
$465M
AUM Growth
–
Cap. Flow
+$341M
Cap. Flow %
73.46%
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
QTTB icon
Q32 Bio
QTTB
+$88.1M
2
APRE icon
Aprea Therapeutics
APRE
+$78.6M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$45M
4
CABA icon
Cabaletta Bio
CABA
+$43.5M
5
ARVN icon
Arvinas
ARVN
+$40.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APRE icon
1
Aprea Therapeutics
APRE
$7.4M
$131M 28.17%
+142,633
New +$78.6M
QTTB icon
2
Q32 Bio
QTTB
$450M
$115M 24.66%
+307,551
New +$88.1M
CRNX icon
3
Crinetics Pharmaceuticals
CRNX
$8.89B
$59.3M 12.75%
+2,362,286
New +$45M
ARVN icon
4
Arvinas
ARVN
$520M
$56.6M 12.19%
+1,378,423
New +$40.4M
CABA icon
5
Cabaletta Bio
CABA
$439M
$51.3M 11.03%
+3,669,263
New +$43.5M
IDYA icon
6
IDEAYA Biosciences
IDYA
$3.41B
$26M 5.59%
+3,463,066
New +$24.7M
SCPH
7
DELISTED
scPharmaceuticals
SCPH
$18.4M 3.96%
+3,253,440
New +$16.6M
CDTX
8
DELISTED
Cidara Therapeutics
CDTX
$7.71M 1.66%
+100,326
New +$4.59M
VIVE
9
DELISTED
VIVEVE MED INC
VIVE
$10K ﹤0.01%
+808
New +$23K

Similar funds

LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

5AM Venture Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for 5AM Venture Management, which disclosed 9 positions worth $465M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Q32 Bio: 307,551 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • 5AM Venture Management's largest Q4 2019 buy was Q32 Bio: 307,551 shares worth $115M.
  • 5AM Venture Management's ten largest holdings make up 100% of its $465M portfolio in Q4 2019.
  • 5AM Venture Management disclosed 9 positions in Q4 2019, its first 13F filing on record.

Based on 5AM Venture Management's 13F filing for Q4 2019, filed 5 Feb 2020.